Global pharma major Lupin Limited (Lupin) today announced the launch of Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% and 0.06%, in the United States. Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% and 0.06% are bioequivalent to Atrovent® Nasal Spray, 0.03% and 0.06%, of Boehringer Ingelheim Pharmaceuticals, Inc..

全球制药巨头卢平有限公司（Lupin）今天宣布在美国推出异丙托溴铵鼻喷雾剂（Ipratropium Bromide Nasal Solution），0.03% 和 0.06%。异丙托溴铵鼻喷雾剂，0.03% 和 0.06%，与勃林格殷格翰制药公司（Boehringer Ingelheim Pharmaceuticals, Inc.）的Atrovent®鼻喷雾剂，0.03% 和 0.06% 生物等效。

Ipratropium Bromide Nasal Solution (Nasal Spray) 0.03% is indicated for the symptomatic relief of rhinorrhea associated with allergic and nonallergic perennial rhinitis in adults and children aged 6 years and older.  Ipratropium Bromide Nasal Solution (Nasal Spray) 0.06% is indicated for the symptomatic relief of rhinorrhea associated with the common cold or seasonal allergic rhinitis for adults and children aged 5 years and older..

0.03%异丙托溴铵鼻喷雾剂（鼻腔喷雾）适用于缓解6岁及以上成人和儿童因过敏性及非过敏性常年性鼻炎引起的流涕症状。0.06%异丙托溴铵鼻喷雾剂（鼻腔喷雾）适用于缓解5岁及以上成人和儿童因普通感冒或季节性过敏性鼻炎引起的流涕症状。

Ipratropium Bromide Nasal Solution (RLD Atrovent®) had estimated annual sales of USD 63 million in the U.S. (IQVIA MAT May 2025).

溴化异丙托品鼻腔溶液（参考上市药物Atrovent®）在美国的年销售额估计为6300万美元（IQVIA MAT 2025年5月数据）。

About Lupin

关于Lupin

Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S.

Lupin Limited是一家总部位于印度孟买的全球制药领导者，产品销往100多个市场。Lupin专注于制药产品，包括品牌和仿制配方、复杂仿制药、生物技术产品以及活性药物成分。该公司受到全球医疗保健专业人士和消费者的信赖，在印度和美国拥有强大的市场地位。

across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 23,000 professionals.

跨越多个治疗领域，包括呼吸系统、心血管、抗糖尿病、抗感染、胃肠、中枢神经系统和女性健康。Lupin在全球拥有15个最先进的生产场地和7个研究中心，以及超过23,000名专业人员的专职团队。

Lupin is committed to improving patient health outcomes through its subsidiaries – Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions..

通过其子公司——Lupin诊断、Lupin数字健康和Lupin制造解决方案，Lupin致力于改善患者的健康结果。